Partnerships and Community
Gilead is dedicated to developing innovative medicines for life-threatening illnesses – and we recognize that it takes more than medicine to address challenges people and communities face.
That’s why we work with organizations around the world to launch programs that help improve access to care by eliminating barriers and advancing education.
Together We Can Stop the Virus
Together we can stop the virus is an awareness campaign developed by Gilead in collaboration with 10 patient associations and ICAR (Italian Conference on AIDS and Antiviral Research). The purpose of the initiative is to share in a new way what it means to live with HIV today.
Fear of diagnosis, injury, starting therapy, but also the achievement of a better quality of life are some of the topics covered through the Augmented Reality works of six Italian artists to create an interactive experience that highlights some of the challenges faced by people living with HIV. Since premiering at BASE Milano in 2019, the artists have added to the show, demonstrating new obstacles encountered by people with HIV during the COVID-19 pandemic.
In 2021, the project continued with the first "Call for Artists" dedicated to HIV, a competition aimed at encouraging artists and creative professionals under 40 to provide additional artistic content to enrich the exhibit.
From Idea to Reality: Gilead’s Fellowship Program and Community Award Program in Italy
Gilead launched the Fellowship Program and Community Award in Italy in 2011, with the goal of encouraging research institutions and patient associations to submit projects that support people living with life-threatening diseases. A team of independent judges evaluates submissions that demonstrate the potential to improve quality of life or provide assistance to patients through scientific, social and technological means. Now in its 10th year, the Fellowship Program and Community Award has supported more than 400 projects proposed by more than 300 Italian researchers and patient associations with financial support of 10 million euros.
C as Curable
C as Curable is the information and awareness campaign for hepatitis C carried out by Gilead in collaboration with the Italian Society of Infectious and Tropical Diseases (SIMIT), the Bridge Foundation, EpaC Onlus, the Italian Association for the Study of the Liver (AISF), Plus Onlus and Maraini Foundation. The initiative aims to increase awareness of hepatitis C and to encourage people who may have contracted the virus to see a doctor.
Cell Therapy Open Source
The Cell Therapy Open Source Project was founded in collaboration with the National Advanced Therapies Observatory, with the Italian Association Against Leukemia-Lymphoma and Myeloma, the Working Group on Hematological Neoplasms in F.A.V.O. and La Lampada di Aladino association. The project aims to show how CAR T cell-based therapies are changing biomedicine and the history of some serious onco-hematological pathologies.
The first report produced as part of this project is the e-book CAR T Therapies, From the Laboratory to the Patient, an in-depth study prepared with input from relevant experts in Italy. The report focuses on accessibility for patients, covering the complexity of production and administration, and issues around costs and sustainability for the National Health.
This project is named as “open source” as it is in continuous evolution, and will be updated as the fields of gene and cellular therapies evolve in the future.
Our Commitment to the Pandemic
Since the beginning of the COVID-19 pandemic, Gilead has worked to help solve public health challenges in Italy. We launched the Community Grants Program, a donation program that provided 500,000 euros to fund Italian nonprofit organizations engaged in relief effort. The program supported almost 60 projects submitted by the entire Italian nonprofit sector between March and May 2020. For its contribution to society, the Community Grants Program received the patronage of the “Benessere Italia” Control Room of the Presidency of the Italian Government.
Additionally, Gilead has provided support to hospitals committed to dealing with the health emergency, donating 1.5 million euros to the Italian Civil Protection for the purchase of personal protective equipment and other medical supplies.